Benzinga Global Small Cap Conference: How Do Investors Pick Winners In The Psychedelics Space?

Simeon Schnapper, a managing partner at JLS Fund, took 30 minutes from his busy schedule to share his insights into what makes a winner in the psychedelics space. “I don’t think a lot of people fully understand what psychedelics are, I know there’s companies going public right now, there’s great investment opportunity, but also great opportunity to bend the arc of history,” said Schnapper, in his presentation at the Benzinga Global Small Cap Conference on Thursday. JLS Fund, an investment firm that sits at the intersection of psychedelics and technology, holds shares in companies such as MindMed (NASDAQ: MNMD), Atai Life Sciences and Wesana Health (CSE: WESA), which went public earlier this week. New Trends In Psychedelics: Schnapper sees a few trends picking up in the sector. One involves M&A, as smaller companies are acquired by larger public or soon-to-be-public, companies. Another trend is the integration of digital therapeutics into business models. Electronic devices that can amplify or emulate psychedelic experiences are also ... Full story available on Benzinga.com psychedelics psychedelic investors shares cse nasdaq mindmed atai life sciences wesana health atai wesana

Read More